Vir Biotechnology Statistics Share Statistics Vir Biotechnology has 138.92M
shares outstanding. The number of shares has increased by 0.87%
in one year.
Shares Outstanding 138.92M Shares Change (YoY) 0.87% Shares Change (QoQ) 0.49% Owned by Institutions (%) 80.06% Shares Floating 94.58M Failed to Deliver (FTD) Shares 3,670 FTD / Avg. Volume 0.28%
Short Selling Information The latest short interest is 11.85M, so 8.57% of the outstanding
shares have been sold short.
Short Interest 11.85M Short % of Shares Out 8.57% Short % of Float 13.86% Short Ratio (days to cover) 9.59
Valuation Ratios The PE ratio is -1.92 and the forward
PE ratio is -2.01.
Vir Biotechnology's PEG ratio is
0.12.
PE Ratio -1.92 Forward PE -2.01 PS Ratio 13.48 Forward PS 60.1 PB Ratio 0.87 P/FCF Ratio -2.2 PEG Ratio 0.12
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Vir Biotechnology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 8.71,
with a Debt / Equity ratio of 0.09.
Current Ratio 8.71 Quick Ratio 8.71 Debt / Equity 0.09 Debt / EBITDA -0.18 Debt / FCF -0.22 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $181.88K Profits Per Employee $-1.28M Employee Count 408 Asset Turnover 0.05 Inventory Turnover n/a
Taxes Income Tax -1.15M Effective Tax Rate 0.22%
Stock Price Statistics The stock price has increased by -25.97% in the
last 52 weeks. The beta is 1.27, so Vir Biotechnology's
price volatility has been higher than the market average.
Beta 1.27 52-Week Price Change -25.97% 50-Day Moving Average 5.01 200-Day Moving Average 6.46 Relative Strength Index (RSI) 64.05 Average Volume (20 Days) 1,291,523
Income Statement In the last 12 months, Vir Biotechnology had revenue of 74.2M
and earned -521.96M
in profits. Earnings per share was -3.83.
Revenue 74.2M Gross Profit 73.36M Operating Income -587.16M Net Income -521.96M EBITDA -537.61M EBIT -552.17M Earnings Per Share (EPS) -3.83
Full Income Statement Balance Sheet The company has 222.95M in cash and 97.89M in
debt, giving a net cash position of 125.06M.
Cash & Cash Equivalents 222.95M Total Debt 97.89M Net Cash 125.06M Retained Earnings -759.78M Total Assets 1.19B Working Capital 630.7M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -446.35M
and capital expenditures -7.3M, giving a free cash flow of -453.65M.
Operating Cash Flow -446.35M Capital Expenditures -7.3M Free Cash Flow -453.65M FCF Per Share -3.33
Full Cash Flow Statement Margins Gross margin is 98.86%, with operating and profit margins of -791.27% and -703.4%.
Gross Margin 98.86% Operating Margin -791.27% Pretax Margin -704.95% Profit Margin -703.4% EBITDA Margin -724.49% EBIT Margin -791.27% FCF Margin -611.35%
